Membrane phospholipids and hormone-sensitive lipolysis in fat cells

Isolated fat cells from rats which have been made hypothyroid do not give a lipolytic response to catecholamines. A recent report has suggested that catecholamine-sensitive lipolysis may be correlated with an “unmasking” of receptors by linoleic acid rich phospholipids in the fat cell membrane. No apparent differences in phospholipid fatty acid composition could be found in membrane “ghosts” prepared from normal and hypothyroid rats.     

对鼻咽癌恶性转化基因Tx表达的初步研究

运用杂交组化及Ｎｏｒｔｈｅｒｎ法,对中国人鼻咽癌细胞株恶性转化基因Ｔｘ的表达进行了初步研究。结果表明该基因在鼻咽癌细胞株中表达１．３ｋｂｍＲＮＡ,但表达强度较低,在ＨＰＶ阳性或阴性人宫颈癌细胞中均无表达,ＥＢＶ阴性的Ｂ淋巴细胞系及ＨＴＬＶ－１阳性的Ｔ细胞系中为阴性,而在ＥＢＶ阳性的Ｂ９５－８及Ｒａｊｉ细胞中Ｔｘ基因表达强烈,从而提示ＨＰＶ及ＨＴＬＶ－１不增强Ｔｘ的表达水平,而ＥＢＶ可能使Ｔｘ基因活化．这为进一步研究ＥＢＶ与Ｔｘ等瘤基因协同作用提供了新的依据。     

Conversion of arachidonic acid to two novel products by a cytochrome P450-dependent mixed-function oxidase in polymorphonuclear leukocytes

Canine polymorphonuclear leukocytes metabolize [14C] arachidonic acid into 2 unidentified products, separated by thin-layer chromatography and high performance liquid chromatography, and called peak 1 and peak 2. The formation of peak 1 is maximal at 5 minutes and then declines, while the synthesis of peak 2 increases throughout the 30 minute incubation period. The formation of peak 1 and, to a lesser extent, peak 2, was enhanced after dual inhibition of lipoxygenase and cyclo-oxygenase enzymes with BW755C (94 microns) or nafazatrom (37 microns), or after incubation in a calcium-free buffer. In contrast, the formation of these products was inhibited by SKF-525A (50 microns), suggesting a cytochrome P450-dependent mechanism. The presence of cytochrome P450 in neutrophil microsomes was confirmed by measuring aryl hydrocarbon hydroxylase activity and cytochrome P450 content.     

Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer

Colorectal cancer is a major cause of mortality and whilst up to 80% of sporadic colorectal tumours are considered preventable, trends toward increasing obesity suggest the potential for a further increase in its worldwide incidence. Novel methods of colorectal cancer prevention and therapy are therefore of considerable importance. Non-steroidal anti-inflammatory drugs (NSAIDs) are chemopreventive against colorectal cancer, mainly through their inhibitory effects on the cyclooxygenase isoform COX-2. COX enzymes represent the committed step in prostaglandin biosynthesis and it is predominantly increased COX-2-mediated prostaglandin-E₂ (PGE₂) production that has a strong association with colorectal neoplasia, by promoting cell survival, cell growth, migration, invasion and angiogenesis. COX-1 and COX-2 inhibition by traditional NSAIDs (for example, aspirin) although chemopreventive have some side effects due to the role of COX-1 in maintaining the integrity of the gastric mucosa. Interestingly, the use of COX-2 selective NSAIDs has also shown promise in the prevention/treatment of colorectal cancer while having a reduced impact on the gastric mucosa. However, the prolonged use of high dose COX-2 selective inhibitors is associated with a risk of cardiovascular side effects. Whilst COX-2 inhibitors may still represent viable adjuvants to current colorectal cancer therapy, there is an urgent need to further our understanding of the downstream mechanisms by which PGE₂ promotes tumorigenesis and hence identify safer, more effective strategies for the prevention of colorectal cancer. In particular, PGE₂ synthases and E-prostanoid receptors (EP1–4) have recently attracted considerable interest in this area. It is hoped that at the appropriate stage, selective (and possibly combinatorial) inhibition of the synthesis and signalling of those prostaglandins most highly associated with colorectal tumorigenesis, such as PGE₂, may have advantages over COX-2 selective inhibition and therefore represent more suitable targets for long-term chemoprevention. Furthermore, as COX-2 is found to be overexpressed in cancers such as breast, gastric, lung and pancreatic, these investigations may also have broad implications for the prevention/treatment of a number of other malignancies.     

Interaction of nonsteroidal anti-inflammatory drugs with membranes: In vitro assessment and relevance for their biological actions

Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used drugs in the world due to their anti-inflammatory, analgesic and antipyretic properties. Nevertheless, the consumption of these drugs is still associated with the occurrence of a wide spectrum of adverse effects. Regarding the major role of membranes in cellular events, the hypothesis that the biological actions of NSAIDs may be related to their effect at the membrane level has triggered the in vitro assessment of NSAIDs-membrane interactions. The use of membrane mimetic models, cell cultures, a wide range of experimental techniques and molecular dynamics simulations has been providing significant information about drugs partition and location within membranes and also about their effect on diverse membrane properties. These studies have indeed been providing evidences that the effect of NSAIDs at membrane level may be an additional mechanism of action and toxicity of NSAIDs. In fact, the pharmacokinetic properties of NSAIDs are closely related to the ability of these drugs to interact and overcome biological membranes. Moreover, the therapeutic actions of NSAIDs may also result from the indirect inhibition of cyclooxygenase due to the disturbing effect of NSAIDs on membrane properties. Furthermore, increasing evidences suggest that the disordering effects of these drugs on membranes may be in the basis of the NSAIDs-induced toxicity in diverse organ systems. Overall, the study of NSAIDs-membrane interactions has proved to be not only important for the better understanding of their pharmacological actions, but also for the rational development of new approaches to overcome NSAIDs adverse effects.     

Phoneutria nigriventer toxin Tx3-1 blocks A-type K+ currents controlling Ca2+ oscillation frequency in GH3 cells

GH3 cells present spontaneous Ca2+ action potentials and oscillations of intracellular Ca2+, which can be modified by altering the activity of K+ or Ca2+ channels. We took advantage of this spontaneous activity to screen for effects of a purified toxin (Tx3-1) from the venom of Phoneutria nigriventer on ion channels. We report that Tx3-1 increases the frequency of Ca2+ oscillations, as do two blockers of potassium channels, 4-aminopyridine and charybdotoxin. Whole-cell patch clamp experiments show that Tx3-1 reversibly inhibits the A-type K+ current (I(A)) but does not block other K+ currents (delayed-rectifying, inward-rectifying, and large-conductance Ca2+-sensitive) or Ca2+ channels (T and L type) in these cells. In addition, we describe the sequence of a full cDNA clone of Tx3-1, which shows that Tx3-1 has no homology to other known blockers of K+ channels and gives insights into the processing of this neurotoxin. We conclude that Tx3-1 is a selective inhibitor of I(A), which can be used to probe the role of this channel in the control of cellular function. Based on the effect of Tx3-1, we suggest that I(A) is an important determinant of the frequency of Ca2+ oscillations in unstimulated GH3 cells.     

Kinetic analysis of the polymerization and depolymerization of β2-microglobulin-related amyloid fibrils in vitro

β₂-Microglobulin-related (Aβ₂M) amyloidosis is a serious complication in patients on long-term dialysis, and partial unfolding of β₂-microglobulin (β₂-m) is believed to be prerequisite to its assembly into Aβ₂M amyloid fibrils. Many kinds of amyloid-associated molecules (e.g., apolipoprotein E (apoE), glycosaminoglycans (GAGs), proteoglycans (PGs)) may contribute to the development of Aβ₂M amyloidosis. The formation of Aβ₂M amyloid fibrils in vitro was first observed at low pH (2.0–3.0). Very recently, low concentrations of 2,2,2-trifluoroethanol (TFE) and the sub-micellar concentration of sodium dodecyl sulfate, a model for anionic phospholipids, have been reported to cause the extension of Aβ₂M amyloid fibrils at a neutral pH, inducing partial unfolding of β₂-m and stabilization of the fibrils. Moreover, apoE, GAGs and PGs were found to stabilize Aβ₂M amyloid fibrils at a neutral pH, forming a stable complex with the fibrils. Some GAGs, especially heparin enhanced the fibril extension in the presence of TFE at a neutral pH. Some PGs, especially biglycan also induced the polymerization of acid-denatured β₂-m. These findings are consistent with the hypothesis that in vivo, specific molecules that affect the conformation and stability of β₂-m and amyloid fibrils will have significant effects on the deposition of Aβ₂M amyloid fibrils.     

Tx基因与Igk基因的同源性研究及其在不同细胞株的表达

本文对以前报道的Ｔｘ基因２．８ｋｂ片段的核苷酸序列与人免疫球蛋白ｋａｐｐａ链Ｃ区基因的核苷酸序列及其编码产物的氨基酸序列进行了同源性比较。结果表明,Ｔｘ基因与ｋａｐｐａ链Ｃ区基因的同源性高达９９．５％以上,编码区的同源性高达１００％。从而提示Ｔｘ基因与ｋａｐｐａ链Ｃ区基因可能是同一种基因。限制性内切酶图谱及Ｓｏｕｔｈｅｒｎ印迹杂交分析,也进一步支持这一观点。本文还报道了ｋａｐｐａ链Ｃ区基因在不同细     

O2-芋螺毒素Tx7.29抑制钙通道电流及镇痛活性研究（英文）

目的 海洋肉食性软体动物芋螺的毒液是生物活性多肽的一个宝贵来源。这些活性多肽大多是富含二硫键的神经毒素,通常称为芋螺毒素。在本研究中,发现了一个全新的O2超家族芋螺毒素Tx7.29,通过对其进行功能研究,期望发现新的镇痛药候选物。方法 从织锦芋螺毒管c DNA文库中克隆得到Tx7.29的c DNA序列。通过化学合成,制得了Tx7.29的成熟肽,并通过质谱鉴定了其分子质量。通过膜片钳实验和动物实验确定Tx7.29的生物学功能。结果 Tx7.29的c DNA序列编码了一个包含68个氨基酸残基的芋螺毒素前体,由19个残基的信号肽、28个残基的前片段和22个残基的成熟肽组成。圆二色谱分析表明,β转角和反平行片层是Tx7.29二级结构中的主要组分。通过膜片钳实验发现,Tx7.29可以显著抑制大鼠背根神经节细胞的钙通道电流,但对钠电流和钾电流没有明显作用。在小鼠热板疼痛试验中,从0.5到4小时,Tx7.29以剂量依赖性的方式,增加了试验小鼠的热板潜伏时间。Tx7.29对ND7/23细胞无明显细胞毒性。结论 Tx7.29有望成为一种镇痛药物先导化合物,同时它的发现也扩大了O2-芋螺毒素的作用范围。